Contemporary Concepts in Management of Acute Otitis Media in Children

https://doi.org/10.1016/j.otc.2014.06.006Get rights and content

Section snippets

Key points

  • Acute otitis media (AOM) should be distinguished from chronic otitis media with effusion.

  • Clinical practice guidelines have been updated to refine the “observation” option for treatment of AOM, with an emphasis on precise diagnosis.

  • The bacteriology of AOM has been changed by the use of pneumococcal vaccines, but high dose amoxicillin or amoxicillin–clavulanate are good choices when initial antibiotic therapy is prescribed for AOM.

  • Tympanostomy tubes are an option for children with recurrent AOM,

Introduction and definitions

Acute otitis media (AOM) is a common disorder of early childhood, and among the most common reasons for referral of a young child to the otolaryngologist. Although the majority of children with AOM are managed by primary care providers without the need for specialty consultation, children with recurrent episodes, severe symptoms, or complications of AOM can require prompt otolaryngologic evaluation and surgical treatment. Although AOM affects many children, and tympanostomy tube placement is

Epidemiology

AOM is a common disease in children. In the United States, 8.8 million children (11.8%) under the age of 18 were reported to have ear infections in 2006, with an estimated total treatment cost of $2.8 billion.5 Antibiotics are prescribed for AOM more frequently than for any other illness of childhood.6 The epidemiology of AOM has evolved over the past decade, with a decrease in clinician visits for suspected AOM by 33% from 1995–1996 to 2005–2006.6 The reasons for the decrease in clinician

Pathophysiology and microbiology

AOM is often, although not always, preceded by a viral upper respiratory tract infection.11 Inflammation leads to edema in the nasal cavities and nasopharynx, causing functional obstruction of the Eustachian tube and the development of negative pressure in the middle ear from a lack of equilibration. Microbe-containing secretions from the upper airway mucosa move into the middle ear owing to the pressure differential, where they become trapped. Bacterial replication and infection may ensue.12,

Diagnosis

Because there is no gold standard for the diagnosis of AOM, short of tympanocentesis and culture of middle ear fluid, there is controversy about the best clinical means to accurately diagnose acute middle ear infection. Diagnostic accuracy is challenging because of the wide spectrum of signs and symptoms that develop throughout the course of the disease, the difficulties in examining the ears of young children who may be uncooperative or have occluding cerumen, and the overlap of symptoms

Management

Management goals for AOM are to decrease severity and duration of symptoms, principally by controlling pain and fever, to improve hearing outcomes, and to prevent complications.7, 36

Complications

AOM can progress to severe complications, including acute mastoiditis, meningitis, and intracranial abscess. Complications can be thought of as (a) intracranial, extratemporal, (b) intratemporal, extracranial, and (c) extratemporal, extracranial (Table 3). The most common complication seen by the clinician is TM perforation with suppuration and otorrhea, but a busy clinician can expect to see facial nerve paralysis or acute mastoiditis (Fig. 1) in a young child with AOM as well. Such

Recurrent AOM and tympanostomy tubes

Recurrent AOM is defined as at least 3 episodes of AOM in 6 month or 4 episodes in 1 year, with one of these episodes in the preceding 6 months.7 Risk factors that have been identified for recurrent AOM include group child care attendance, male gender, winter season, passive smoking, pacifier uses, presence of siblings, lack of breastfeeding, and symptoms for longer than 10 days at presentation.52 The 2013 AAP guideline examines the role of both prophylactic antibiotic therapy and tympanostomy

Prevention

Several anticipatory health interventions and environmental factors can reduce the incidence of AOM and are endorsed in the 2013 AAP guideline. Vaccination with the conjugate pneumococcal vaccine (PCV7) decreased physician visits for AOM, although there was a subsequent trend toward serotype replacement where AOM (and complications) were caused by nonvaccine serotypes.17, 19 Vaccination with the more recent PCV13, which covers 6 additional S pneumoniae serotypes, should be encouraged.17, 19, 20

Complementary and alternative medicine

Although many dietary modifications and complementary and alternative medicine options have been proposed and are available for prevention and treatment of AOM, high-quality evidence does not exist to support their use. Naturopathic herbal extracts have been used as topical analgesics and have been found to provide similar rates of pain relief to conventional anesthetic ear drops,41 although good evidence of benefit is lacking.39

A randomized, double-blind, placebo-controlled study involving 328

“At-risk” children and otitis media

Children with medical comorbidities, neurocognitive and/or communication impairment, and craniofacial anomalies that affect Eustachian tube function may be at increased risk for frequent AOM or consequences of middle ear disease and associated conductive hearing loss. These children are usually excluded from clinical trials that evaluate the management and outcomes of otitis media, and in fact are excluded from the 2013 AAP AOM guideline recommendations. The AAO-HNS Clinical Practice guideline

Summary

Management of AOM requires keen diagnostic skills to recognize the signs, symptoms, and severity of the illness and to determine the otoscopic hallmarks of acute middle ear infection. Recent clinical practice guidelines emphasize the need for precise diagnosis, whereas understanding the generally favorable natural history of AOM may allow many children to be observed without initial antibiotic treatment. Prevention of AOM can include vaccinations, environmental modifications, maintenance of

First page preview

First page preview
Click to open first page preview

References (100)

  • J. Dohar

    Microbiology of otorrhea in children with tympanostomy tubes: implications for therapy

    Int J Pediatr Otorhinolaryngol

    (2003)
  • E.L. Goldblatt et al.

    Topical ofloxacin versus systemic amoxicillin/clavulanate in purulent otorrhea in children with tympanostomy tubes

    Int J Pediatr Otorhinolaryngol

    (1998)
  • J.R. Levi et al.

    Complementary and alternative medicine for pediatric otitis media

    Int J Pediatr Otorhinolaryngol

    (2013)
  • K. Hatakka et al.

    Treatment of acute otitis media with probiotics in otitis-prone children-a double-blind, placebo-controlled randomised study

    Clin Nutr

    (2007)
  • S. Lyford-Pike et al.

    Otolaryngologic manifestations of skeletal dysplasias in children

    Otolaryngol Clin North Am

    (2012)
  • S.R. Shott et al.

    Hearing loss in children with Down syndrome

    Int J Pediatr Otorhinolaryngol

    (2001)
  • R.M. Rosenfeld et al.

    Clinical practice guideline: tympanostomy tubes in children

    Otolaryngol Head Neck Surg

    (2013)
  • M.L. Casselbrant et al.

    Efficacy of antimicrobial prophylaxis and of tympanostomy tube insertion for prevention of recurrent acute otitis media: results of a randomized clinical trial

    Pediatr Infect Dis J

    (1992)
  • C.D. Bluestone et al.

    Otitis media in infants and children

    (2007)
  • R.M. Rosenfeld et al.

    Evidence-based otitis media

    (2003)
  • A. Soni

    Ear infections (otitis media) in children (0-17): use and expenditures, 2006

    (2008)
  • C.G. Grijalva et al.

    Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings

    JAMA

    (2009)
  • A.S. Lieberthal et al.

    The diagnosis and management of acute otitis media

    Pediatrics

    (2013)
  • A. Coco et al.

    Management of acute otitis media after publication of the 2004 AAP and AAFP clinical practice guideline

    Pediatrics

    (2010)
  • Z. Grossman et al.

    Physician specialty is associated with adherence to treatment guidelines for acute otitis media in children

    Acta Paediatr

    (2013)
  • C.B. Forrest et al.

    Improving adherence to otitis media guidelines with clinical decision support and physician feedback

    Pediatrics

    (2013)
  • B. Winther et al.

    Temporal relationships between colds, upper respiratory viruses detected by polymerase chain reaction, and otitis media in young children followed through a typical cold season

    Pediatrics

    (2007)
  • T. Chonmaitree et al.

    Role of viruses in middle-ear disease

    Ann N Y Acad Sci

    (1997)
  • T. Heikkinen et al.

    Importance of respiratory viruses in acute otitis media

    Clin Microbiol Rev

    (2003)
  • A. Ruohola et al.

    Microbiology of acute otitis media in children with tympanostomy tubes: prevalences of bacteria and viruses

    Clin Infect Dis

    (2006)
  • J.R. Casey et al.

    New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine

    Pediatr Infect Dis J

    (2010)
  • M.S. Grubb et al.

    Microbiology of acute otitis media, Puget sound region, 2005-2009

    Clin Pediatr

    (2010)
  • K.L. O'Brien et al.

    Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial

    J Infect Dis

    (2007)
  • Centers for Disease Control and Prevention

    Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children - Advisory Committee on Immunization Practices (ACIP), 2010

    MMWR Morbid Mortal Wkly Rep

    (2010)
  • M.K. Laine et al.

    Symptoms or symptom-based scores cannot predict acute otitis media at otitis-prone age

    Pediatrics

    (2010)
  • Centers for Disease Control and Prevention. Get smart: know when antibiotics work. Available at:...
  • R.M. Rosenfeld et al.

    Natural history of untreated otitis media

    Laryngoscope

    (2003)
  • American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media

    Diagnosis and management of acute otitis media

    Pediatrics

    (2004)
  • P.A. Tahtinen et al.

    A placebo-controlled trial of antimicrobial treatment for acute otitis media

    N Engl J Med

    (2011)
  • A. Hoberman et al.

    Treatment of acute otitis media in children under 2 years of age

    N Engl J Med

    (2011)
  • D.H. Newman et al.

    Treatment of acute otitis media in children

    N Engl J Med

    (2011)
  • A. Darby-Stewart et al.

    Antibiotics for acute otitis media in young children

    Am Fam Physician

    (2011)
  • R.P. Venekamp et al.

    Antibiotics for acute otitis media in children

    Cochrane Database Syst Rev

    (2013)
  • M.E. Pichichero et al.

    Evolving microbiology and molecular epidemiology of acute otitis media in the pneumococcal conjugate vaccine era

    Pediatr Infect Dis J

    (2007)
  • R.M. Rosenfeld et al.

    Otitis media with effusion clinical practice guideline

    Am Fam Physician

    (2004)
  • E. Onusko

    Tympanometry

    Am Fam Physician

    (2004)
  • N. Shaikh et al.

    Development and preliminary evaluation of a parent-reported outcome instrument for clinical trials in acute otitis media

    Pediatr Infect Dis J

    (2009)
  • American Academy of Pediatrics et al.

    The assessment and management of acute pain in infants, children, and adolescents

    Pediatrics

    (2001)
  • P. Burke et al.

    Acute red ear in children: controlled trial of non-antibiotic treatment in general practice

    BMJ

    (1991)
  • R. Foxlee et al.

    Topical analgesia for acute otitis media

    Cochrane Database Syst Rev

    (2006)
  • Cited by (0)

    Disclosure: The authors have nothing to disclose.

    View full text